Developing personalized medicine is a new popular approach in oncology. Pharmacokinetics, pharmacogenetics and pharmacogenomics are promising tools to achieve this goal. Despite being an ...

Short- and long-term toxicity affects more than 40% of cancer patients and can be life threatening or permanently disabling. [21] Pharmacogenomics in this field has the potential to improve the ...

demonstrating the potential benefits of personalized medicine in breast cancer treatment. Pharmacogenomics: The study of how genes affect a person's response to drugs, aiming to develop effective ...

Pharmacogenomics is the study of how genes affect a person's response to drugs. In the context of metastatic colorectal cancer (mCRC), pharmacogenomics plays a crucial role in personalizing ...

Our Pharmacogenomics and Transport micro-credential is a three-course series encompassing several aspects of pharmacogenomics from transport to current events incorporating cancer and nutrition. Each ...

Pharmacogenomics, the understanding of how genes impact an individual’s response to medications, provides a potential outlet to better optimised therapies. There have been great strides made in ...

Jun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura, MD, PhD, demonstrated that treatment and ...

Know about the revolutionary therapies, personalised medicine and cancer treatments that are changing the game!

Pharmacogenomics (PGx) is a subset of precision medicine that focuses on the genetics behind different pharmaceutical interactions, toxicities, and efficacies. PGx improves drug discovery and ...

The FDA, which has stopped short of requiring DPYD testing for patients before receiving fluoropyrimidines, emphasized the importance of discussing it.